Nivolumab in Metastatic Melanoma: Good Efficacy and Tolerability in Elderly Patients
Abstract
Share and Cite
De Luca, R.; Meraviglia, S.; Blasi, L.; Maiorana, A.; Cicero, G. Nivolumab in Metastatic Melanoma: Good Efficacy and Tolerability in Elderly Patients. Curr. Oncol. 2020, 27, 75-80. https://doi.org/10.3747/co.27.5293
De Luca R, Meraviglia S, Blasi L, Maiorana A, Cicero G. Nivolumab in Metastatic Melanoma: Good Efficacy and Tolerability in Elderly Patients. Current Oncology. 2020; 27(2):75-80. https://doi.org/10.3747/co.27.5293
Chicago/Turabian StyleDe Luca, R., S. Meraviglia, L. Blasi, A. Maiorana, and G. Cicero. 2020. "Nivolumab in Metastatic Melanoma: Good Efficacy and Tolerability in Elderly Patients" Current Oncology 27, no. 2: 75-80. https://doi.org/10.3747/co.27.5293